1.41
price up icon0.71%   0.01
after-market 시간 외 거래: 1.38 -0.03 -2.13%
loading
전일 마감가:
$1.40
열려 있는:
$1.43
하루 거래량:
73,476
Relative Volume:
0.21
시가총액:
$5.64M
수익:
-
순이익/손실:
$-6.78M
주가수익비율:
-0.3946
EPS:
-3.5729
순현금흐름:
$-4.67M
1주 성능:
-4.08%
1개월 성능:
+14.63%
6개월 성능:
+18.49%
1년 성능:
+914.39%
1일 변동 폭
Value
$1.38
$1.45
1주일 범위
Value
$1.33
$1.50
52주 변동 폭
Value
$0.10
$6.80

Clearmind Medicine Inc Stock (CMND) Company Profile

Name
명칭
Clearmind Medicine Inc
Name
전화
-
Name
주소
-
Name
직원
4
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
CMND's Discussions on Twitter

Clearmind Medicine Inc 주식(CMND)의 최신 뉴스

pulisher
Oct 22, 2024

Clearmind Medicine (NASDAQ:CMND) Shares Down 12.3% – What’s Next? - Defense World

Oct 22, 2024
pulisher
Oct 11, 2024

Clearmind Medicine Inc [CMND] Revenue clocked in at $0.00 million, down -51.60% YTD: What’s Next? - The DBT News

Oct 11, 2024
pulisher
Oct 11, 2024

Clearmind advances trial for alcohol use disorder therapy - Investing.com

Oct 11, 2024
pulisher
Oct 11, 2024

Clearmind advances trial for alcohol use disorder therapy By Investing.com - Investing.com Australia

Oct 11, 2024
pulisher
Oct 10, 2024

Clearmind Medicine Inc (NASDAQ: CMND): Is Its Value Too High Compared To Others? - Stocks Register

Oct 10, 2024
pulisher
Oct 10, 2024

Clearmind Medicine Inc Inc. (CMND) Price Performance: A Technical Analysis Perspective - The InvestChronicle

Oct 10, 2024
pulisher
Oct 10, 2024

Examining CMND’s book value per share for the latest quarter - US Post News

Oct 10, 2024
pulisher
Oct 10, 2024

Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site - Marketscreener.com

Oct 10, 2024
pulisher
Oct 09, 2024

Rail Vision secures $20 million equity deal with Yorkville - Investing.com

Oct 09, 2024
pulisher
Oct 08, 2024

SciSparc gains as Clearmind partnership yields 3 new international patent applications - MSN

Oct 08, 2024
pulisher
Oct 01, 2024

Clearmind Medicine Completed Type A Meeting with the FDA - GlobeNewswire

Oct 01, 2024
pulisher
Sep 30, 2024

SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment - Marketscreener.com

Sep 30, 2024
pulisher
Sep 26, 2024

Clearmind Medicine appoints new board member - Investing.com

Sep 26, 2024
pulisher
Sep 24, 2024

Clearmind, SciSparc slide amid weight-loss study results - MSN

Sep 24, 2024
pulisher
Sep 19, 2024

Could Psychedelics End Binge Drinking? A Breakthrough Patent Says Yes - MSN

Sep 19, 2024
pulisher
Sep 17, 2024

Clearmind Medicine patents new addiction treatment - Investing.com India

Sep 17, 2024
pulisher
Sep 16, 2024

SciSparc Unveils Breakthrough Ibogaine Therapy Patent - TipRanks

Sep 16, 2024
pulisher
Sep 16, 2024

Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering - The Bakersfield Californian

Sep 16, 2024
pulisher
Sep 16, 2024

SciSparc-Clearmind Medicine Collaboration Announces the - GlobeNewswire

Sep 16, 2024
pulisher
Sep 16, 2024

SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination Therapy - StockTitan

Sep 16, 2024
pulisher
Sep 14, 2024

Contrasting Clearmind Medicine (NASDAQ:CMND) and Phio Pharmaceuticals (NASDAQ:PHIO) - Defense World

Sep 14, 2024
pulisher
Sep 13, 2024

Clearmind Medicine files patent for PTSD treatment compounds - Investing.com

Sep 13, 2024
pulisher
Sep 12, 2024

Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment - Morningstar

Sep 12, 2024
pulisher
Sep 11, 2024

SciSparc shares up on patents filed for psychedelic compounds with Clearmind - MSN

Sep 11, 2024
pulisher
Sep 07, 2024

SciSparc and Clearmind Innovate Mental Health Treatment - TipRanks

Sep 07, 2024
pulisher
Sep 06, 2024

Clearmind Medicine files patent for novel MDMA therapy - Investing.com

Sep 06, 2024
pulisher
Sep 06, 2024

SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment - Yahoo Finance UK

Sep 06, 2024
pulisher
Sep 06, 2024

SciSparc-Clearmind Medicine Collaboration Leads to - GlobeNewswire

Sep 06, 2024
pulisher
Sep 06, 2024

SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent ... - The Bakersfield Californian

Sep 06, 2024
pulisher
Sep 02, 2024

A History of Outperforming Analyst Forecasts and Beating the Odds: Clearmind Medicine Inc (CMND) - SETE News

Sep 02, 2024
pulisher
Sep 02, 2024

Financial Metrics Check: Clearmind Medicine Inc (CMND)’s Ratios for Trailing Twelve Months - The Dwinnex

Sep 02, 2024
pulisher
Aug 29, 2024

Clearmind and SciSparc file patent for ketamine-based therapy - Investing.com

Aug 29, 2024
pulisher
Aug 29, 2024

SciSparc and Clearmind Innovate in Mental Health Therapy - TipRanks

Aug 29, 2024
pulisher
Aug 29, 2024

Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment - Morningstar

Aug 29, 2024
pulisher
Aug 26, 2024

Clearmind Biomedical Announces FDA Clearance and First U.S. Surgery of the Neuroblade System for Minimally Invasive Neurosurgery - PR Newswire

Aug 26, 2024
pulisher
Aug 25, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Market Exclusive

Aug 25, 2024
pulisher
Aug 23, 2024

CMND’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

Aug 23, 2024
pulisher
Aug 22, 2024

Clearmind receives patent for drug to treat binge behavior - Green Market Report

Aug 22, 2024
pulisher
Aug 22, 2024

Clearmind Medicine Inc (CMND) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle

Aug 22, 2024
pulisher
Aug 21, 2024

Clearmind Medicine secures new US patent for binge behavior regulator - Investing.com India

Aug 21, 2024
pulisher
Aug 21, 2024

Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment - Yahoo Finance

Aug 21, 2024
pulisher
Aug 20, 2024

Clearmind Medicine Inc (CMND) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News

Aug 20, 2024
pulisher
Aug 19, 2024

Is CMND’s price to cash per share ratio a concern for investors? - US Post News

Aug 19, 2024
pulisher
Aug 19, 2024

Financial Metrics Unveiled: Clearmind Medicine Inc (CMND)’s Key Ratios in the Spotlight - The Dwinnex

Aug 19, 2024
pulisher
Aug 16, 2024

Thinking about buying stock in Brainstorm Cell Therapeutics, Cle - GuruFocus.com

Aug 16, 2024
pulisher
Aug 16, 2024

Clearmind, Yissum Apply for International Patent for Psychedelics - MarketWatch

Aug 16, 2024
pulisher
Aug 16, 2024

Clearmind Medicine and Yissum Expand Collaboration with International Patent Application for Generation 3.0 Psychedelic Compounds to Treat Mental Disorders - StockTitan

Aug 16, 2024
pulisher
Aug 10, 2024

Clearmind Medicine (NASDAQ:CMND) Stock Price Down 0.8% - Defense World

Aug 10, 2024
pulisher
Aug 09, 2024

Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket - Benzinga

Aug 09, 2024
pulisher
Aug 09, 2024

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday - InvestorPlace

Aug 09, 2024
pulisher
Aug 07, 2024

Clearmind Medicine: New Scientific Publication Shows MEAI's Potential as a Novel Weight Loss Drug - EIN News

Aug 07, 2024

Clearmind Medicine Inc (CMND) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):